Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular mechanisms of differentiation of habenular and thalamic neurons
Hebbian Long-Term Potentiation and Learning in Aplysia
Rebuilding Immunity for Survival
Symposium: Neural Control of Spatial Behavior
Effects of Phencyclidine on Neuronal Function
Recently added grants:
Ventral pallidum molecular mediators in cocaine addiction
Mechanism and Functional Significance of Polarity Reversal in Mechanosensory Organs
Cannabis use and health outcomes among opioid-using people who inject drugs in the context of cannabis legalization
Neurocognitive Consequences of Adolescent Marijuana Use
The effects of exposure to violence on risk for substance abuse: neural mechanisms and community level moderators
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM62201-5-0-2
Application #
7568588
Study Section
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Early Therapeutics Development with Phase II Emphasis
/ University of Chicago
$662,981
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
Vokes, Everett E. /
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
Comments
Be the first to comment on this grant